Assertio Therapeutics, Inc.

549300L2A9NTF1JVDP20

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: July 18, 2018

Address

Country: United States
Legal address: C/O CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE19808 WILMINGTONUnited States (US-DE)
Head office: 251 LITTLE FALLS DRIVE19808 WILMINGTONUnited States (US-DE)

Identifier

LEI: 549300L2A9NTF1JVDP20
Registered: July 24, 2018 at 02:31 PM UTC
Last updated: September 11, 2026 at 07:34 PM UTC
Next renewal: July 23, 2019 at 08:34 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 6980073
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 6980073
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300L2A9NTF1JVDP20This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search